EUROPE PROTEIN EXPRESSION MARKET 2019-2028

Lifesciences | Diagnostic & Biotechnology

EUROPE PROTEIN EXPRESSION MARKET 2019-2028

Market By Product Type, Application, End-user And Geography | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

An analysis by Triton Market Research has concluded that the European protein expression market will expand at a CAGR of 10.75% during the forthcoming years 2019-2028.



Report scope can be customized per your requirements. Request For Customization

The countries evaluated in the Europe protein expression market are:

           Italy

           The United Kingdom

           Germany

           Russia

           France

           Spain  

           Rest of Europe

The protein expression market in Europe is witnessing growth due to the rising disposable income of the consumers and easily accessible protein structure database. The growing geriatric population is more prone to chronic diseases, thereby fueling the demand for this market in the region. Moreover, the presence of major contract research organizations that facilitate the research activities of protein expression and its further application in antibody & vaccine production is also contributing to the growth of the regional market.

Europe has a well-developed healthcare infrastructure, and a great emphasis on proteomics and genomics R&D activities is experienced in countries like Switzerland, France, the United Kingdom and Germany. This has fueled the growth of the studied market in the coming years.  

The United Kingdom is considered as an important country in terms of research & development activities. There is a high rate of adoption of new technology in healthcare in the UK, as compared to other countries in the region. The country is making huge investments in this sector and is expected to grow even further. These factors are consequently leading to the development of the protein expression market in the country.

Lonza is a company providing products & services to the healthcare, pharmaceutical and life sciences industries. The company provides custom development and production of drugs and drug delivery systems and anti-microbial solutions. It has two major business operational segments, pharma & biotech and specialty ingredients. The specialty ingredients segment focuses on the development and marketing of anti-microbial applications, covering hygiene, preservatives, capsules & food supplements and nutrition & personal care products.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    EUROPE PROTEIN EXPRESSION MARKET - SUMMARY        

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION     

2.2. KEY INSIGHTS      

2.2.1.   THERAPEUTIC APPLICATIONS HOLDS THE LARGEST SHARE 

2.3. PORTER’S FIVE FORCE ANALYSIS   

2.3.1.   THREAT OF NEW ENTRANTS   

2.3.2.   THREAT OF SUBSTITUTE           

2.3.3.   BARGAINING POWER OF SUPPLIERS

2.3.4.   BARGAINING POWER OF BUYERS     

2.3.5.   THREAT OF COMPETITIVE RIVALRY  

2.4. MARKET ATTRACTIVENESS INDEX  

2.5. VENDOR SCORECARD 

2.6. MARKET DRIVERS         

2.6.1.   GROWING PREVALENCE OF CHRONIC DISEASES

2.6.2.   RISE IN HEALTHCARE EXPENDITURE          

2.6.3.   INCREASING R&D IN THE FIELDS OF GENOMICS AND PROTEOMICS

2.7. MARKET RESTRAINTS  

2.7.1.   HIGH COST OF PROTEIN EXPRESSION SYSTEMS

2.7.2.   STRINGENT REGULATORY APPROVAL        

2.8. MARKET OPPORTUNITIES       

2.8.1.   RISE IN PHARMACEUTICAL MARKET IN EMERGING REGIONS 

2.9. MARKET CHALLENGES

2.9.1.   LACK OF EFFECTIVE SYSTEMS FOR POST-TRANSLATIONAL MODIFICATIONS   

2.10. IMPACT OF COVID-19 ON PROTEIN EXPRESSION MARKET   

3.    EUROPE PROTEIN EXPRESSION MARKET OUTLOOK - BY PRODUCT TYPE      

3.1. REAGENTS

3.2. EXPRESSION VECTORS           

3.3. COMPETENT CELLS      

3.4. INSTRUMENTS    

3.5. SERVICES 

4.    EUROPE PROTEIN EXPRESSION MARKET OUTLOOK - BY APPLICATION

4.1. THERAPEUTIC     

4.2. INDUSTRIAL         

4.3. RESEARCH          

5.    EUROPE PROTEIN EXPRESSION MARKET OUTLOOK - BY END-USER    

5.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES   

5.2. ACADEMIC RESEARCH INSTITUTES

5.3. CONTRACT RESEARCH ORGANIZATIONS 

5.4. OTHER END-USERS      

6.    EUROPE PROTEIN EXPRESSION MARKET – REGIONAL OUTLOOK           

6.1. UNITED KINGDOM          

6.2. GERMANY 

6.3. FRANCE    

6.4. SPAIN         

6.5. ITALY          

6.6. RUSSIA      

6.7. REST OF EUROPE                      

7.    COMPETITIVE LANDSCAPE

7.1. AGILENT TECHNOLOGIES INC

7.2. BD (BECTON, DICKINSON AND COMPANY)

7.3. BIO-RAD LABORATORIES INC

7.4. GENSCRIPT          

7.5. LIFESENSORS

7.6. MERCK KGAA       

7.7. PROMEGA CORPORATION      

7.8. QIAGEN 

7.9. TAKARA HOLDINGS INC

7.10. THERMO FISHER SCIENTIFIC INC

7.11. LONZA      

7.12. NEW ENGLAND BIOLABS       

7.13. BIOTECHRABBIT           

7.14. PROMAB  

7.15. PEAK PROTEINS LTD

8.    METHODOLOGY & SCOPE  

8.1. RESEARCH SCOPE & DELIVERABLES        

8.2. SOURCES OF DATA       

8.3. RESEARCH METHODOLOGY  

List of table

TABLE 1: EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: EUROPE PROTEIN EXPRESSION MARKET, BY PRODUCT TYPE, 2019-2028 (IN $ MILLION)

TABLE 4: EUROPE PROTEIN EXPRESSION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)

TABLE 5: EUROPE PROTEIN EXPRESSION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)

TABLE 6: EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)

List of Figures

FIGURE 1: EUROPE PROTEIN EXPRESSION MARKET, BY THERAPEUTIC, 2019-2028 (IN $ MILLION)

FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

FIGURE 3: MARKET ATTRACTIVENESS INDEX

FIGURE 4: EUROPE PROTEIN EXPRESSION MARKET, BY REAGENTS, 2019-2028 (IN $ MILLION)

FIGURE 5: EUROPE PROTEIN EXPRESSION MARKET, BY EXPRESSION VECTORS, 2019-2028 (IN $ MILLION)

FIGURE 6: EUROPE PROTEIN EXPRESSION MARKET, BY COMPETENT CELLS, 2019-2028 (IN $ MILLION)

FIGURE 7: EUROPE PROTEIN EXPRESSION MARKET, BY INSTRUMENTS, 2019-2028 (IN $ MILLION)

FIGURE 8: EUROPE PROTEIN EXPRESSION MARKET, BY SERVICES, 2019-2028 (IN $ MILLION)

FIGURE 9: EUROPE PROTEIN EXPRESSION MARKET, BY THERAPEUTIC, 2019-2028 (IN $ MILLION)

FIGURE 10: EUROPE PROTEIN EXPRESSION MARKET, BY INDUSTRIAL, 2019-2028 (IN $ MILLION)

FIGURE 11: EUROPE PROTEIN EXPRESSION MARKET, BY RESEARCH, 2019-2028 (IN $ MILLION)

FIGURE 12: EUROPE PROTEIN EXPRESSION MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2028 (IN $ MILLION)

FIGURE 13: EUROPE PROTEIN EXPRESSION MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2019-2028 (IN $ MILLION)

FIGURE 14: EUROPE PROTEIN EXPRESSION MARKET, BY CONTRACT RESEARCH ORGANIZATIONS, 2019-2028 (IN $ MILLION)

FIGURE 15: EUROPE PROTEIN EXPRESSION MARKET, BY OTHER END-USERS, 2019-2028 (IN $ MILLION)

FIGURE 16: EUROPE PROTEIN EXPRESSION MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)

FIGURE 17: UNITED KINGDOM PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 18: GERMANY PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 19: FRANCE PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 20: SPAIN PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 21: ITALY PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 22: RUSSIA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 23: REST OF EUROPE PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;